Tuesday 11 December 2018 - 03:08
In Business 38 Years - Since 1980
FREE SHIPPING TO THE U.S. AND 33 OTHER COUNTRIES! [Read more].
Search:
E-4997 Erlotinib, Free Base, >99%
Synonyms : [CP-358774] [OSI-774] [Ro 50-8231]
Related Terms : [Tarceva]
- Size
- US $
- €
- £
- ¥
- 500 mg
- 37
- 31
- 27
- 4,100
- In stock
- 1 g
- 48
- 40
- 35
- 5,300
- In stock
- 2 g
- 72
- 61
- 53
- 7,900
- In stock
- 5 g
- 136
- 115
- 100
- 15,000
- In stock
- 10 g
- 238
- 201
- 175
- 26,300
- In stock
Note: Our Euro, Pound, and Yen prices are revised regularly to account for currency exchange rate fluctuations.
To receive a Quotation for catalog sizes of this product and/or any other products, please add them to your shopping cart and click on the “REQUEST A QUOTATION” box.
Click Here to Request a Quotation for Larger Quantities
Free Shipping and Handling to the U.S. and 33 Other Countries
- M.W. 393.44
- C22H23N3O4
- [183321-74-6]
- M.I. 14: 3672
Storage: Store at or below -20 ºC. Solubility: Soluble in DMSO at 100 mg/mL; soluble in ethanol at 10 mg/mL with warming; very poorly soluble in water; maximum solubility in plain water is estimated to be about 5-20 µM; buffers, serum, or other additives may increase or decrease the aqueous solubility. Disposal: A.
- This is the free base form of erlotinib; please see our product Erlotinib, Hydrochloride Salt, Cat. No. E-4007, for further technical information. The hydrochloride salt form of erlotinib, not the free base, is used in the erlotinib formulation for use in humans.
- Erlotinib (as the hydrochloride salt) is the active ingredient in the drug product sold under the trade name Tarceva®. This drug has been approved in at least one country for use in patients with pancreatic cancer, non-small cell lung cancer and several other types of cancer. NOTE: THE ERLOTINIB, FREE BASE RESEARCH COMPOUND SOLD BY LC LABORATORIES IS NOT TARCEVA®, AND IS NOT FOR HUMAN USE.
- This erlotinib product is the free base, whose CAS number is given above. The CAS number of the hydrochloride salt is 183319-69-9.
- Related CAS numbers: 248594-19-6 for erlotinib mesylate.
- Sold for laboratory or manufacturing purposes only; not for human, medical, veterinary, food, or household use.
- This product is offered for R&D use in accordance with (i) 35 USC 271(e)+A13(1) in the U.S.; (ii) Section 69.1 of Japanese Patent Law in Japan; (iii) Section 11, No. 2 of the German Patent Act of 1981 in Germany; (iv) Section 60, Paragraph 5b of the U.K. Patents Act of 1977 in the U.K.; (v) Sections 55.2(1) and 55.2(6) and other common law exemptions of Canadian patent law; (vi) Section 68B of the Patents Act of 1953 in New Zealand together with the amendment of same by the Statutes Amendment Bill of 2002; (vii) such related legislation and/or case law as may be or become applicable in the aforementioned countries; and (viii) such similar laws and rules as may apply in various other countries.
- Not available in some countries; not available to some institutions; not available for some uses.
